Competitive TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study

✍ Scribed by Yanik, Gregory; Grupp, Stephan; Pulsipher, Michael A.; Levine, John E.; Schultz, Kirk R.; Wall, Donna A.; Langholz, Bryan; Dvorak, Christopher C.; Alangaden, Keith; Cooke, Kenneth R.

• Book ID: 122031868
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 214 KB
• Volume: 19
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2012.11.032